DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
EPI-743 400mg
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
6
パーキンソン病
1
6. パーキンソン病
臨床試験数
:
2,307
/
薬物数
:
2,007
- (
DrugBank
:
349
) /
標的遺伝子数
:
188
-
標的パスウェイ数
:
199
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT01923584
(
ClinicalTrials.gov
)
September 2013
20130900
13/8/2013
20130813
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease
Parkinson's Disease
Drug:
EPI-743 400mg
;Drug: EPI-743 200mg
University of South Florida
Edison Pharmaceuticals Inc
Completed
40 Years
75 Years
Both
15
Phase 2
United States